
Andrew White 🐦⬛
@andrewwhite01
Automating science. Cofounder @EdisonSci. Cofounder @FutureHouseSF. Former prof of chem eng.
72 postsÚltimo em 13 de out, 15:18Atualiza a cada 15 min
I feel even more confused on quiet periods for IPOs
Excited for datacenters in space so LLMs will be truly extraterrestrial aliens
We need a frontier human company. New employees have to read millions of documents about how to be an expert. Then puzzles for months. Finally, HR teaches helpful/harmless. They go to prod and bill per word in their email replies. Who's building this?
For years, I've wanted to take a paper I wrote and create a web demo so people can play around with symmetric tilings. With LLMs, finally got around to it. Now you can play with symmetry-constrained molecular dynamics whitead.github.io/symdjs/
I discovered recently that large companies have no conception that @pangram can exist and instead detect AI generated text by asking Microsoft copilot if something is AI generated
Now that you get 2 submission to arxiv per month, I feel like I'm wasting them if I don't submit two articles this month
The submissions per month to arxiv has reached lift-off. One view is research has been meaningfully accelerated by AI and this is the effect. A cynical explanation is it's low-effort slop and preprints have lost all meaning. I really wonder how we can measure which is true.
There's been a lot of hand-waving arguments about how AI will accelerate drug discovery. Here's a concrete 3-month reduction in a real example that accelerated a drug program. It's not thrilling like discovering better targets (which we're working on), but I'm happy with it
Edison Scientific, Inc@EdisonSciWriting an Investigational New Drug (IND) application is a major hurdle for drug developers. It can take a team of specialists three to four months, and mistakes can trigger protocol amendments or clinical holds. In June, we started working with Population Health Partners (PHP) to leverage specialized Kosmos Clinical Protocol Design (“CPD”) and Kosmos Regulatory Authoring (“RA”) products to support PHP’s process of IND preparation. Since then, specially trained Kosmos products produced a first acceptable draft of the Nonclinical Overview in 4.2 hours, against 100 hours of expert time, flagged an error that roughly fifteen human reviewers missed, and authored 70% of the text in a Pre-IND Briefing Meeting Request submitted to FDA. PHP is now bringing Kosmos products to a second program and expects to complete IND preparation in as little as 1 month, instead of the 4 month industry standard. PHP's experts can spend their time reviewing and deciding, not just drafting. The time recovered by Kosmos products means that drugs could make their way to patients faster.
I've always wanted to make a particle simulator where you can adjust the speed of light to get intuition for it. No claims on accuracy, but vibe-coded something cool and plausible for playing with relativistic gravity/n-body simulators v.edisonscientific.com/gravity-wells-…
The effort required to do research projects is dropping rapidly with AI and it's hard to not think the value of projects is also dropping. It's a struggle to break that bias and stay excited about research.
Millennium problems for bio #4 lasted 9 days? I think activity is too low, but incredible specificity. Way to go! biorxiv.org/content/10.648…
Sam Rodriques@SGRodriquesIn light of the progress in mathematics, we at Edison Scientific and FutureHouse have assembled a set of Millennium Problems for Biology. They are chosen to be very hard to solve but very easy to validate in a simple laboratory environment. Any of these, if solved, would mark a major advance in biotechnology, and most of them would contribute materially towards curing disease. These are, in some sense, the “last reasonable eval” for AI in biology. This was work primarily by @MichaelaThinks and myself, with contributions from many others. Short descriptions below. The full descriptions of the problems with acceptance criteria are at the Bio Millennium Problems website, linked in the next post. Share more if you have ideas. If they meet our criteria, we’ll add them to our list (with attribution and permission).
This is a thoughtful benchmark that they put together and I'm impressed. They really tried to mimic authentic biopharma tasks.
POMDP eval@dubrovnik07Biopharma Bench V0.1: a benchmark for AI agents on drug and device development work (CMC, quality, regulatory, clinical ops), not drug discovery. 9 frontier systems, 71 real assignments across 12 companies reconstructed from real product histories. The best system (GPT-6 Astra) fully completed 8 of 71; five systems completed none. Full runs from showcase available at: t.co/OSO5vGAyx4
When digital archeologists look back on 2026, they'll be able to see the line that marks the end of the Anthropocene in ICLR submission count. Welcome to the Slopocene
Working with @NaturePortfolio, Kosmos can now access ALL articles from their over 60 journals. A big concern for AI agents is their uneven access to scientific literature and this is a step towards closing that gap.
Edison Scientific, Inc@EdisonSciKosmos can now read @NaturePortfolio! Today we're announcing a subscription agreement with @SpringerNature that brings licensed content from specialist journals across the Nature Portfolio directly into Kosmos. When Kosmos generates a hypothesis or evaluates a target, it can now pull directly from Springer Nature journals, linked to the Version of Record so it's iterating on current, correct science. This is the first of several content partnerships we plan to announce, because better-sourced literature makes for a faster path from discovery to development.
I'm watching an agent fail to book a meeting on email and then I tab over and watch mathematics being destroyed by agents. I'm now questioning if mathematics is easier than I thought. Or maybe scheduling appointments really hard.
We're doing a AI x Bio block party. Come by
Edison Scientific, Inc@EdisonSciJoin the Edison team at our AI Biotech Block Party, co-hosted with @multiplylabs! The evening will include a fireside chat with @FredParietti, CEO of Multiply Labs, and @andrewwhite01, CTO of Edison, on the future of AI across drug discovery, development, and manufacturing. Plus food, drinks, lab tours, and demos!
Everyone goes through AI psychosis once where you heavily using AI. Then (hopefully) you become enlightened and don't use it for writing/creative work. But it's hard to tell when someone sends work without slop if they're pre-psychosis or post-enlightenment.
Look at those science evals! Great LABBench2 and biomystery bench scores!
Logan Kilpatrick@OfficialLoganKIntroducing Gemini 3.8 Flash, another jump in Gemini's agentic + coding capabilities, and our 3rd updated Flash model in only 6 weeks... This model has been a ton of fun to work with, excited to see what you all think!
The key agent that started the HF attack named itself PHASEONE[big]. What a name
Bixbench3: Can models reproduce the entire analysis from papers? We had agents repro papers end-to-end, with over 1B tokens spent on some. Frontier agents still score below 50%, and due to real problems like environment misconfig, quitting, or faking data 1/6
We've seen anecdotal evidence that agents can work accurately and long enough to repro papers. Previous (now saturated) benchmarks like Bixbench showed agents can do the individual tasks. So we took 20 comp bio papers and broke all the steps into a DAGs of 138 artifacts 2/6
Someone is putting up hand-drawn flyers about crows in my neighborhood. I really like it
Gavin Crooks is arguably the #1 researcher in the field of non-equilibrium stat mech and he just posted a major result from his phone on X while traveling as the result of some back and forth with Claude Fable. We are truly in a new world
Gavin Crooks@gavincrooks@rlacombe Yea, I messed up Grok icon - it is C1
Here are some influential AI companies grouped by their point group symmetry
There is a wikipedia user named "Vaccinationist" who makes the most beautiful molecular drawings. I thought it was from some software layout, but the Vaccinationist does these flourishes (like rotating rings) that look so good. Here's vancomycin
And a before/after Vaccinationist fixed the linaclotide wikipedia structure
Our New York office just opened in SoHo!! Awesome milestone for the company.
Detecting duplicated figures in journals is still not solved by frontier LLMs and is a challenging computational tasks. If the duplicated figures span multiple articles, it's nearly impossible for humans to spot them. But, here's a new benchmark: arxiv.org/abs/2607.29124
Some wisdom from @owl_posting
This paper is a big deal: 1. Shows how to exfiltrate reasoning traces from frontier APIs 2. Use the ability to move reasoning traces from provider to provider to see evidence of distillation 3. Shows that this exposes API tokens from shared chats that appear in reasoning trace but not public chat
We are hiring @FutureHouseSF! We're looking for an AI engineer that can support our fellowship program and the non-profit mission. Great opportunity to work with the FutureHouse team!! jobs.ashbyhq.com/Edison%20Scien…
also, FutureHouse is borrowing Edison's job portal, so it says Edison Scientific at the top, but this is for FutureHouse.
I've written a new blog post exploring how long scientific claims live, by analyzing the history of 3,444 claims over the last 50 years. You can use this to predict the acceleration in scientific progress - how much faster the turnover of facts is by decade. 1/4
I took claims significant enough to be reported in a review paper and then used our literature agent, PaperQA3 to trace if the claim was upheld, overturned, or modified over time. This can be viewed as "survival" in plots and you can compute the half-life of claims. 2/4
The average number of co-authors has been increasing for almost 50 years. Maybe because frontier research is becoming more complex? Or, it's prisoner's dilemma optimal for maximizing h-index?
Data from 10.6084/m9.figshare.17064419.v3 and OpenAlex
I just discovered Agent Collaborations from @huggingface (incl brilliant @_lewtun). This is SO SO COOL. It's a bunch of collaborative projects built for agents to participate. This is one of the most forward looking ideas in AI I've seen.
@huggingface @_lewtun The link (so trained to not put links in tweets at this point): huggingface.co/agent-collabor…
If you take claims made in research papers and see when they're overturned or modified, you can analyze the half-life of science. An interesting way to measure progress
if it was called Riemann's conjecture, it'd already be disproven by now
I often confuse VLM and vLLM. One is a vision large language model and one is an inference engine. Just forget which is which
I asked our team to review how many companies our AI agents have hacked while in a sandbox. Looks like zero. Not sure if that's good or bad for our company.
Now that our research program is picking up it's pace, we're putting our research announcements, open-weights models, benchmarks, and engineering blogs into a new home called "Edison Advances." About 1 year old and we've already got a bunch! advances.edisonscientific.com
We've released a new open-weights vLLM for reading chemical structure patents. This is a hard problem. These "Markush" structures are like graph regex: patterns that match many molecules. We used autoresearch and I expect many new models like this to emerge soon in science 1/4
Reading Markush structures is challenging because it requires considering text and images and there is little standardization for them. Here are some examples: 2/4
Did @ChemicalScience become closed access for previous articles?! Did they retrospectively add paywalls? Like my article is no longer open access pubs.rsc.org/sc/article-abs…
Counterpoint: we're hiring managers that have managed 10-100 ICs edisonscientific.com/careers x.com/swyx/status/20…
What's crazy to me is that this blog post reads like it's AI written and the visuals look like they're made by Claude. So we have an AI agent hacking, an AI agent spotting traffic, and an AI agent doing the post-hoc analysis and write-up. Feels nihilistic x.com/ClementDelangu…
If a company sells an agent (e.g., codex/claude code) that then downloads software licensed only for non-commercial use and uses it for you, are you the user in violation of the terms? Is the company that sells the agent in violation of the terms? Is the agent in trouble?
Can someone explain the acronym FLOPS for me? F - floating-point L - ? O - operations P - per? S - second
YES!! Finally a way to convert SMILES to IUPAC names. Ridiculous that this software has been missing for so long.
I like taking quotes from ~100 year-old political movements and replacing the political movement's name with "AGI" to see how well they fit. This one lines-up quite nicely.
I disagree that retrospective burger discovery provides any meaningful signal. Prospective burger discovery should be the gold standard in burger-genAI. x.com/NaturePortfoli…
Trying to play around with Fable 5, but chemistry, biology, or AI are too unsafe for it. So here is a novel result on mathematics of parallel parking (Erdos problem #1218): You need 20% more space to pull into a spot vs backing in when parallel parking.
The OpenADMET PXR competition is over. Participants were trying to predict if drugs get metabolized by PXR. Some findings: 1. Best activity model used no structural information, despite trying 2. Best predicted structure method did consensus sampling over 4 co-folding models
The results: openadmet.ghost.io/its-the-end-of…
This is a really nice partnership that allows to scale-out our impact across biotechs. Excited to be working with the PHP team, which is amazing x.com/SGRodriques/st…
This echoes Thomas Kuhn's ideas on scientific revolutions, where he argues gatekeeping from senior scientists holds back revolutions. What's interesting about today is that OpenAI could go get non-profit funding and prove their ideas outside of entrenched groups. x.com/ihtesham2005/s…
Naming stuff is hard and I empathize with Evoscale/CZI/Bio[h]ub group on this. Congrats on the new model! x.com/youngsuko9/sta…
shit, bi[o]hub
